These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 18468455)

  • 1. VCP binding influences intracellular distribution of the slow Wallerian degeneration protein, Wld(S).
    Wilbrey AL; Haley JE; Wishart TM; Conforti L; Morreale G; Beirowski B; Babetto E; Adalbert R; Gillingwater TH; Smith T; Wyllie DJ; Ribchester RR; Coleman MP
    Mol Cell Neurosci; 2008 Jul; 38(3):325-40. PubMed ID: 18468455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WldS can delay Wallerian degeneration in mice when interaction with valosin-containing protein is weakened.
    Beirowski B; Morreale G; Conforti L; Mazzola F; Di Stefano M; Wilbrey A; Babetto E; Janeckova L; Magni G; Coleman MP
    Neuroscience; 2010 Mar; 166(1):201-11. PubMed ID: 20018231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The slow Wallerian degeneration protein, WldS, binds directly to VCP/p97 and partially redistributes it within the nucleus.
    Laser H; Conforti L; Morreale G; Mack TG; Heyer M; Haley JE; Wishart TM; Beirowski B; Walker SA; Haase G; Celik A; Adalbert R; Wagner D; Grumme D; Ribchester RR; Plomann M; Coleman MP
    Mol Biol Cell; 2006 Mar; 17(3):1075-84. PubMed ID: 16371511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wld S requires Nmnat1 enzymatic activity and N16-VCP interactions to suppress Wallerian degeneration.
    Avery MA; Sheehan AE; Kerr KS; Wang J; Freeman MR
    J Cell Biol; 2009 Feb; 184(4):501-13. PubMed ID: 19237597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wld S protein requires Nmnat activity and a short N-terminal sequence to protect axons in mice.
    Conforti L; Wilbrey A; Morreale G; Janeckova L; Beirowski B; Adalbert R; Mazzola F; Di Stefano M; Hartley R; Babetto E; Smith T; Gilley J; Billington RA; Genazzani AA; Ribchester RR; Magni G; Coleman M
    J Cell Biol; 2009 Feb; 184(4):491-500. PubMed ID: 19237596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting NMNAT1 to axons and synapses transforms its neuroprotective potency in vivo.
    Babetto E; Beirowski B; Janeckova L; Brown R; Gilley J; Thomson D; Ribchester RR; Coleman MP
    J Neurosci; 2010 Oct; 30(40):13291-304. PubMed ID: 20926655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the neuroprotective slow Wallerian degeneration (WldS) gene in non-neuronal tissues.
    Wishart TM; Brownstein DG; Thomson D; Tabakova AM; Boothe KM; Tsao JW; Gillingwater TH
    BMC Neurosci; 2009 Dec; 10():148. PubMed ID: 20015399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotinamide mononucleotide adenylyltransferase expression in mitochondrial matrix delays Wallerian degeneration.
    Yahata N; Yuasa S; Araki T
    J Neurosci; 2009 May; 29(19):6276-84. PubMed ID: 19439605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential proteomics analysis of synaptic proteins identifies potential cellular targets and protein mediators of synaptic neuroprotection conferred by the slow Wallerian degeneration (Wlds) gene.
    Wishart TM; Paterson JM; Short DM; Meredith S; Robertson KA; Sutherland C; Cousin MA; Dutia MB; Gillingwater TH
    Mol Cell Proteomics; 2007 Aug; 6(8):1318-30. PubMed ID: 17470424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The slow Wallerian degeneration gene, WldS, inhibits axonal spheroid pathology in gracile axonal dystrophy mice.
    Mi W; Beirowski B; Gillingwater TH; Adalbert R; Wagner D; Grumme D; Osaka H; Conforti L; Arnhold S; Addicks K; Wada K; Ribchester RR; Coleman MP
    Brain; 2005 Feb; 128(Pt 2):405-16. PubMed ID: 15644421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degeneration of neuronal cell bodies following axonal injury in Wld(S) mice.
    Wang AL; Yuan M; Neufeld AH
    J Neurosci Res; 2006 Dec; 84(8):1799-807. PubMed ID: 17022038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NAD(+) and axon degeneration revisited: Nmnat1 cannot substitute for Wld(S) to delay Wallerian degeneration.
    Conforti L; Fang G; Beirowski B; Wang MS; Sorci L; Asress S; Adalbert R; Silva A; Bridge K; Huang XP; Magni G; Glass JD; Coleman MP
    Cell Death Differ; 2007 Jan; 14(1):116-27. PubMed ID: 16645633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neuroprotective WldS gene regulates expression of PTTG1 and erythroid differentiation regulator 1-like gene in mice and human cells.
    Gillingwater TH; Wishart TM; Chen PE; Haley JE; Robertson K; MacDonald SH; Middleton S; Wawrowski K; Shipston MJ; Melmed S; Wyllie DJ; Skehel PA; Coleman MP; Ribchester RR
    Hum Mol Genet; 2006 Feb; 15(4):625-35. PubMed ID: 16403805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The WldS gene delays axonal but not somatic degeneration in a rat glaucoma model.
    Beirowski B; Babetto E; Coleman MP; Martin KR
    Eur J Neurosci; 2008 Sep; 28(6):1166-79. PubMed ID: 18783366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axonal and neuromuscular synaptic phenotypes in Wld(S), SOD1(G93A) and ostes mutant mice identified by fiber-optic confocal microendoscopy.
    Wong F; Fan L; Wells S; Hartley R; Mackenzie FE; Oyebode O; Brown R; Thomson D; Coleman MP; Blanco G; Ribchester RR
    Mol Cell Neurosci; 2009 Dec; 42(4):296-307. PubMed ID: 19683573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cellular distribution of the Wld s chimeric protein and its constituent proteins in the CNS.
    Fang C; Bernardes-Silva M; Coleman MP; Perry VH
    Neuroscience; 2005; 135(4):1107-18. PubMed ID: 16154290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synaptic protection in the brain of WldS mice occurs independently of age but is sensitive to gene-dose.
    Wright AK; Wishart TM; Ingham CA; Gillingwater TH
    PLoS One; 2010 Nov; 5(11):e15108. PubMed ID: 21124744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarm1 Deletion, but Not Wld
    Gilley J; Ribchester RR; Coleman MP
    Cell Rep; 2017 Oct; 21(1):10-16. PubMed ID: 28978465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-nuclear Wld(S) determines its neuroprotective efficacy for axons and synapses in vivo.
    Beirowski B; Babetto E; Gilley J; Mazzola F; Conforti L; Janeckova L; Magni G; Ribchester RR; Coleman MP
    J Neurosci; 2009 Jan; 29(3):653-68. PubMed ID: 19158292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The slow Wallerian degeneration gene in vivo protects motor axons but not their cell bodies after avulsion and neonatal axotomy.
    Adalbert R; Nógrádi A; Szabó A; Coleman MP
    Eur J Neurosci; 2006 Oct; 24(8):2163-8. PubMed ID: 17074042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.